Pasithea Therapeutics KTTAW
NASDAQ KTTAW
$0.00 0.00 (-36.36%)
As of: Sep 9, 2026 · 3:56 PM EDT

Pasithea Therapeutics Corp. (KTTAW) Non-Current Deferred Tax Liability (2022)

Pasithea Therapeutics' (KTTAW) quarterly Non-Current Deferred Tax Liability came in at $592000.0 in Q4 2022.

Analysis

Pasithea Therapeutics Corp. (KTTAW) Non-Current Deferred Tax Liability (2022) Analysis & Trends

Pasithea Therapeutics has disclosed Non-Current Deferred Tax Liability across 1 years of filings, most recently posting $592000.0 for Q4 2022.

  • In Q4 2022, Non-Current Deferred Tax Liability changed N/A year-over-year to $592000.0; the TTM figure through Dec 2022 stood at $592000.0 (changed N/A YoY), while the FY2022 annual figure was $592000.0, changed N/A from the prior year.
  • Non-Current Deferred Tax Liability came in at $592000.0 for Q4 2022 at Pasithea Therapeutics.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $592000.0 in Q4 2022 to a low of $592000.0 in Q4 2022.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 592,000.00